New studies show diabetes drug not proven to improve blood sugar control in pediatric patients
The FDA has approved labeling changes stating that Januvia (sitagliptin), Janumet (sitagliptin and metformin hydrochloride), and Janumet XR (sitagliptin and metformin hydrochloride extended-release) are not proven to improve glycemic (blood sugar) control in pediatric patients.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Diabetes | Drugs & Pharmacology | Endocrinology | Fortamet | Janumet | Januvia | Metformin | Pediatrics | Study | Sugar